is imcivree a glp 1 Rhythm Pharmaceuticals Announces FDA Approval of IMCIVREE® (setmelanotide) for Patients with Acquired Hypothalamic Obesity Bardet-Biedl Syndrome (BBS) | IMCIVREE®
Pay in 4 interest-free payments of $5.18 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30























